AbbVie
ABBV
#26
Rank
โ‚ฌ308.38 B
Marketcap
174,59ย โ‚ฌ
Share price
-0.08%
Change (1 day)
21.19%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total debt

Total debt on the balance sheet as of June 2024 : โ‚ฌ63.74 B

According to AbbVie's latest financial reports the company's total debt is โ‚ฌ63.74 B. A companyโ€™s total debt is the sum of all current and non-current debts.

AbbVie - Total debt on balance sheet (from 2011 to 2024)

Total debt by year

Year Total debt Change
2023-12-31โ‚ฌ53.71 B-8.93%
2022-12-31โ‚ฌ58.98 B-12.49%
2021-12-31โ‚ฌ67.40 B-4.26%
2020-12-31โ‚ฌ70.39 B18.46%
2019-12-31โ‚ฌ59.42 B68.89%
2018-12-31โ‚ฌ35.18 B12.99%
2017-12-31โ‚ฌ31.14 B-11.08%
2016-12-31โ‚ฌ35.02 B20.73%
2015-12-31โ‚ฌ29.01 B135.79%
2014-12-31โ‚ฌ12.30 B15.45%
2013-12-31โ‚ฌ10.65 B-10.12%
2012-12-31โ‚ฌ11.85 B31980.56%
2011-12-31โ‚ฌ36.96 M

Total debt for similar companies or competitors

Company Total debt differencediff. Country
โ‚ฌ61.97 B-2.77%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ48.73 B-23.54%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ26.07 B-59.10%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ56.53 B-11.31%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ21.07 B-66.94%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ6.00 B-90.57%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ19.34 B-69.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ30.26 B-52.53%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ0.23 B-99.64%๐Ÿ‡บ๐Ÿ‡ธ USA